Control versus Cure? How to Determine the Value of Oncology Treatments within Managed Care: 
<br>A Focus on Multiple Myeloma
Held in conjunction with AMCP 26th Annual Meeting & Expo

Wednesday, April 2, 2014. 12:00 PM - 4:00 PM at the Tampa Convention Center, Room 18-19.

You may pre-register for this activity by clicking the link at the bottom of this page.

Hot Topics Include:
  • Point/counter-point debate on value proposition of multiple myeloma drug sequences, treatment combinations, and duration of therapy
  • Response criteria to select and assess treatment success/outcomes
  • Innovative oncology pharmacy benefit models and specialty pharmacy management services
  • Decision-support tools, including comparative effectiveness research (CER), to improve therapeutic decision-making
  • Effective supportive care strategies in oncology
  • Best practices in collaborating with the comprehensive care team to reduce treatment variability

Who Should Attend?
This activity is designed to meet the educational needs of pharmacists, physicians, and other health care professionals attending the AMCP's 26th Annual Meeting & Expo.

Program Overview
Leaders from managed care organizations (MCOs) and other payers have identified the management of multiple myeloma (MM) as a priority area for optimizing clinically- and economically-appropriate care for their members. In light of new drug developments as well as expanding uses of current agents, payers need to appropriately and effectively design benefits that optimize both cost-efficiency and patient outcomes. The symposium format will include a unique point/counter-point design to debate the value proposition of MM drug sequences, treatment combinations, and duration of therapy. The faculty panel includes an academic hematologist, a community-based hematologist, and managed care experts.

Educational Objectives
After completing this activity, the participant should be better able to:
  • Discuss the nature and validity of current debates among members of the hematology community regarding therapeutic decision-making for MM patients, including the clinical data that support various perspectives
  • Demonstrate the value of comparative effectiveness research (CER) as a decision-support tool to appropriately invest resources and reduce treatment variability among MM patients
  • Implement innovative oncology pharmacy benefit models and specialty pharmacy management services
  • Provide accurate and appropriate counsel as part of the managed care treatment team

Distinguished Faculty Presenters

Rafat Abonour, MD
Professor of Medicine
Medical Director, Bone Marrow Transplant Program
Medical Director, Stem Cell Laboratory
Indiana University Simon Cancer Center
Diana Brixner, PhD, RPh
Professor and Chair, Department of Pharmacology
Executive Director
Outcomes Research Center, College of Pharmacy
Director of Outcomes, Personalized Health Care Program
University of Utah
Jeffrey D. Dunn, PharmD, MBA
Senior Vice President
VRx Pharmacy Services, LLC
Joseph Mikhael MD, MEd, FRCPC, FACP
Associate Dean, Mayo School of Graduate Medical Education
Deputy Director - Education, Mayo Clinic Cancer Center
Associate Professor, Mayo College of Medicine
Mayo Clinic in Arizona

Date and Time
Wednesday, April 2, 2014
12:00 PM - 4:00 PM
Tampa Convention Center
Room 18-19
Tampa, FL

Agenda
12:00 pm Registration and Lunch
12:30 pm Pre-activity Learning Assessment and Opening Comments
Douglas McKell, Impact Education, LLC Moderator
12:40 pm Debates in Multiple Myeloma Management: Diagnosis and Risk Stratification
Rafat Abonour, MD


Treatment Selection and Duration of Therapy
Joseph Mikhael MD, MEd, FRCPC, FACP
2:10 pm Applying CER as a Decision-Support Tool for Anti-Myeloma Agents to Reduce Treatment Variability
Diana Brixner, PhD, RPh
2:45 pm Collaborating to Improve Care of Multiple Myeloma Patients: Pharmacy Benefit Designs and Specialty Pharmacy Cancer Care Services
Jeffrey D. Dunn, PharmD, MBA
3:25 pm Audience Question and Answer Session
3:55 pm Key Takeaways and Closing Comments

Continuing Education

Physician Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Postgraduate Institute for Medicine and Impact Education, LLC. Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation
Postgraduate Institute for Medicine designates this live activity for a maximum of 3.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Pharmacist Accreditation Statement
Postgraduate Institute for Medicine is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.



Credit Designation
Postgraduate Institute for Medicine designates this continuing education activity for 3.5 contact hours (0.35 CEUs) of the Accreditation Council for Pharmacy Education. (Universal Activity Number - (0809-9999-14-091-L01-P)

Upon receipt of the completed activity evaluation form, transcript information will be available at www .mycpemonitor.net within 4 weeks.

Type of Activity: Application-Based

Fee Information
There is no additional fee for participating in this activity.
Attendance at this symposium requires registration for AMCP's 26th Annual Meeting & Expo.

Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.


Americans with Disabilities Act
Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact Impact Education, LLC, prior to the live event at (215) 619-8812.

Click here to pre-register